NCT05241587

Brief Summary

This study was conducted to evaluate the effect of chewing xylitol gum on thirst, dry mouth and nausea in patients undergoing haemodialysis.Patients undergoing haemodialysis often experience thirst, dry mouth and nausea.This was a prospective, non-randomized experimental study involving a control group. The study was carried out with patients undergoing haemodialysis in a private dialysis centre in the northeast of Turkey between July and December 2018. It was completed with a total of 75 patients assigned to the gum group (n=25), mouth spray group (n=25), and control group (n=25).The patients in the gum group chewed xylitol gum for 10 minutes, five times a day for six weeks. Patients in the mouth spray group used two puffs of mouth spray three times a day. No intervention was made in the control group. Data were collected with the Patient Information Form, Charlson Comorbidity Index, Visual Analogue Scale, Rhodes Index of Nausea, Vomiting and Retching, graduated tube, and pH meter. Data were evaluated with Mann-Whitney U, Pearson Chi-square, Kruskal Wallis and Friedman tests. TREND checklist for non-randomised controlled trials was followed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 3, 2018

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 22, 2019

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 12, 2020

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

January 24, 2022

Completed
22 days until next milestone

First Posted

Study publicly available on registry

February 15, 2022

Completed
Last Updated

February 15, 2022

Status Verified

February 1, 2022

Enrollment Period

1.2 years

First QC Date

January 24, 2022

Last Update Submit

February 4, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Effect of chewing xylitol gum on thirst

    Thirst were evaluated with "Visual Analog Score". VAS is a 10 cm or 100 mm long measuring instrument on a horizontal line with two different ends. The left end of the line is marked as "no" and the right end as "worst".

    6 weeks

  • Effect of chewing xylitol gum on dry mouth

    Dry Mouth were evaluated with "Visual Analog Score". VAS is a 10 cm or 100 mm long measuring instrument on a horizontal line with two different ends. The left end of the line is marked as "no" and the right end as "worst".

    6 weeks

Secondary Outcomes (3)

  • Effect of Xylitol Gum on nausea.

    6 weeks

  • Effect of Xylitol Gum on salivary flow rate.

    6 weeks

  • Effect of Xylitol Gum on oral pH.

    6 weeks

Study Arms (2)

The chewing gum group

EXPERIMENTAL

Gum group patients consisted of patients who chewed "Xylitol Granule Filled Dragee Sugar Free Gum/Xylitol Gum/First X-Fresh". It is reported that the use of xylitol five times a day (not less than three times) is appropriate and effective (Xylitol, 2020; Xylitol, 2006; Llop, et al., 2010). Therefore, this group of patients was allowed to chew xylitol gum for 10 minutes, five times a day for six weeks.

Other: Gum Group:

The mouth spray group

EXPERIMENTAL

The patients in the mouth spray group included those who had been using Oral Spray/Act Dry Mouth Spray regularly as two puffs three times a day at the request of the physician for the last two weeks. This group of patients continued to use the mouth spray at the physician's request.

Other: Mouth Spray Group:

Interventions

Gum Group: Gum group patients consisted of patients who chewed "Xylitol Granule Filled Dragee Sugar Free Gum/Xylitol Gum/First X-Fresh". It is reported that the use of xylitol five times a day (not less than three times) is appropriate and effective (Xylitol, 2020; Xylitol, 2006; Llop, et al., 2010).

The chewing gum group

Mouth Spray Group: The patients in the mouth spray group included those who had been using Oral Spray/Act Dry Mouth Spray regularly as two puffs three times a day at the request of the physician for the last two weeks. This group of patients continued to use the mouth spray at the physician's request.

The mouth spray group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • being 18 years or older,
  • being able to speak and understand Turkish,
  • being oriented to person, place and time,
  • receiving haemodialysis treatment for at least three months,
  • experiencing dry mouth, thirst and nausea,
  • not having any chewing difficulties,
  • not having any dental prosthesis for the gum group,
  • using mouth spray for the last two weeks at the request of the physician for the mouth spray group.

You may not qualify if:

  • hearing and speech impediment,
  • being diagnosed with a psychiatric disease,
  • using antiemetic drugs, being diagnosed with Sjögren's syndrome,
  • receiving radiotherapy or chemotherapy,
  • having a salivary gland infection,
  • previous salivary gland surgery,
  • sucking on ice cubes, chewing mint/lemon peels, and using mouthwash.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karadeniz Techinical University

Trabzon, (554) 326-3222, Turkey (Türkiye)

Location

Related Publications (2)

  • Almutary H, Bonner A, Douglas C. Symptom burden in chronic kidney disease: a review of recent literature. J Ren Care. 2013 Sep;39(3):140-50. doi: 10.1111/j.1755-6686.2013.12022.x. Epub 2013 Jul 4.

    PMID: 23826803BACKGROUND
  • Akgöz N, Arslan S (2017). Examination of Symptoms in Patients Who are on Hemodialysis Treatment. Journal of Nephrology Nursing, 12(1): 20-28.

    RESULT

MeSH Terms

Conditions

XerostomiaNausea

Condition Hierarchy (Ancestors)

Salivary Gland DiseasesMouth DiseasesStomatognathic DiseasesSigns and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Didem Sarımehmet, PhD

    Karadeniz Techinical University

    PRINCIPAL INVESTIGATOR
  • Sevilay Hintistan, PhD

    Karadeniz Techinical University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: This was a prospective, non-randomized experimental study involving a control group.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

January 24, 2022

First Posted

February 15, 2022

Study Start

March 3, 2018

Primary Completion

May 22, 2019

Study Completion

December 12, 2020

Last Updated

February 15, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Locations